FSA
PFE icon

Fort Sheridan Advisors’s Pfizer PFE Stock Holding History

Fort Sheridan Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Sell
117,070
-9,694
-8% -$258K 0.4% 49
2025
Q4 		$3.16M Buy
126,764
+5,526
+5% +$139K 0.4% 46
2025
Q3 		$3.09M Buy
121,238
+4,324
+4% +$107K 0.4% 45
2025
Q2 		$2.83M Buy
116,914
+25,948
+29% +$605K 0.4% 45
2025
Q1 		$2.31M Buy
90,966
+18,248
+25% +$478K 0.35% 56
2024
Q4 		$1.93M Buy
72,718
+370
+0.5% +$10K 0.28% 62
2024
Q3 		$2.09M Buy
72,348
+2,456
+4% +$71.6K 0.32% 61
2024
Q2 		$1.96M Buy
69,892
+1,427
+2% +$39.3K 0.32% 59
2024
Q1 		$1.9M Sell
68,465
-12,692
-16% -$352K 0.36% 53
2023
Q4 		$2.34M Sell
81,157
-24,432
-23% -$739K 0.47% 42
2023
Q3 		$3.5M Sell
105,589
-5,177
-5% -$183K 0.79% 25
2023
Q2 		$4.06M Buy
110,766
+6,465
+6% +$252K 0.93% 23
2023
Q1 		$4.26M Buy
104,301
+24,423
+31% +$1.05M 1.08% 19
2022
Q4 		$4.09M Sell
79,878
-2,298
-3% -$110K 1.33% 15
2022
Q3 		$3.6M Buy
82,176
+1,624
+2% +$78.9K 1.21% 15
2022
Q2 		$4.22M Buy
80,552
+538
+0.7% +$27.4K 1.37% 15
2022
Q1 		$4.14M Buy
80,014
+1,492
+2% +$77.4K 1.22% 15
2021
Q4 		$4.64M Buy
78,522
+1,730
+2% +$85.7K 1.34% 13
2021
Q3 		$3.3M Buy
76,792
+2,327
+3% +$103K 1.08% 18
2021
Q2 		$2.92M Buy
74,465
+12,885
+21% +$501K 0.97% 21
2021
Q1 		$2.23M Buy
61,580
+17,663
+40% +$627K 0.89% 23
2020
Q4 		$1.62M Buy
43,917
+1,710
+4% +$62.7K 0.79% 27
2020
Q3 		$1.47M Buy
42,207
+7,589
+22% +$266K 0.87% 23
2020
Q2 		$1.07M Buy
34,618
+6,818
+25% +$232K 0.66% 28
2020
Q1 		$861K Buy
27,800
+10,465
+60% +$357K 0.63% 29
2019
Q4 		$644K Sell
17,335
-1,688
-9% -$60.1K 0.35% 41
2019
Q3 		$648K Buy
19,023
+1,930
+11% +$70.2K 0.36% 39
2019
Q2 		$703K Buy
17,093
+1,943
+13% +$77.2K 0.41% 37
2019
Q1 		$610K Hold
15,150
– – 0.4% 36
2018
Q4 		$627K Buy
+15,150
New +$629K 0.44% 30

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fort Sheridan Advisors's PFE Position: Q1 2026 in Review

Fort Sheridan Advisors reduced its Pfizer (PFE) stake by 7.6% in Q1 2026, selling an estimated $258K and leaving 117,070 shares worth $3.29M. The position accounts for 0.4% of the portfolio, ranked #49.

Fort Sheridan Advisors first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.64M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fort Sheridan Advisors held 117,070 shares of Pfizer worth $3.29M as of Q1 2026.
  • Fort Sheridan Advisors sold 9,694 Pfizer shares in Q1 2026, an estimated $258K.
  • Pfizer made up 0.4% of Fort Sheridan Advisors's portfolio in Q1 2026, its #49 holding.
  • Fort Sheridan Advisors first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Fort Sheridan Advisors's Pfizer position peaked at $4.64M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fort Sheridan Advisors's 13F filing for Q1 2026, filed 6 May 2026.